Evidence map›Paper›PMID 36415465›Full record

ArticleResearch square2022

A C57BL/6 Mouse model of SARS-CoV-2 infection recapitulates age- and sex-based differences in human COVID-19 disease and recovery.

Michael Davis, Kathleen Voss, J Bryan Turnbull, Andrew T Gustin, Megan Knoll, Antonio Muruato, Tien-Ying Hsiang, Kenneth H Dinnon, Sarah R Leist, Katie Nickel and 5 more

Open access · greenAbstract readPreprint
In one paragraph

Article in Research square, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 12 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 1 country.

Michael DavisUniversity of Washington.
Kathleen VossUniversity of Washington.
J Bryan TurnbullUniversity of Washington.
Andrew T GustinUniversity of Washington.
Megan KnollUniversity of Washington.
Antonio MuruatoUniversity of Washington.
Tien-Ying HsiangUniversity of Washington.
Kenneth H DinnonUniversity of North Carolina at Chapel Hill.
Sarah R LeistUniversity of North Carolina at Chapel Hill.
Katie NickelUniversity of Washington.
Ralph S BaricUniversity of North Carolina at Chapel Hill.
Warren LadigesUniversity of Washington.
Shreeram AkileshUniversity of Washington.
Kelly D SmithUniversity of Washington.
Michael GaleUniversity of Washington.
University of Washington · USUniversity of North Carolina at Chapel Hill · US

Funding

University of Washington Arboviral Research Network (UWARN)U01AI151698 · NIAID · UNIVERSITY OF WASHINGTON · PI Michael Gale, PETER MACGARR RABINOWITZ · 2020 to 2026
$13.3M
Mechanisms of MERS-CoV Entry, Cross-species Transmission and PathogenesisR01AI110700 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BARIC, RALPH S, LI, FANG · 2015 to 2024
$7.4M
Host inflammatory response to SARS-CoV-2R21AI158788 · NIAID · UNIVERSITY OF WASHINGTON · PI GALE, MICHAEL · 2021 to 2022
$485k
NIAID NIH HHS R01 AI110700NIAID NIH HHS R21 AI158788NIAID NIH HHS U01 AI151698
6 · The paper itself

Abstract

We present a comprehensive analysis of SARS-CoV-2 infection and recovery in wild type C57BL/6 mice, demonstrating that this is an ideal model of infection and recovery that accurately phenocopies acute human disease arising from the ancestral SARS-CoV-2. Disease severity and infection kinetics are age- and sex-dependent, as has been reported for humans, with older mice and males in particular exhibiting decreased viral clearance and increased mortality. We identified key parallels with human pathology, including intense virus positivity in bronchial epithelial cells, wide-spread alveolar involvement, recruitment of immune cells to the infected lungs, and acute bronchial epithelial cell death. Moreover, older animals experienced increased virus persistence, delayed dispersal of immune cells into lung parenchyma, and morphologic evidence of tissue damage and inflammation. Parallel analysis of SCID mice revealed that the adaptive immune response was not required for recovery from COVID disease symptoms nor early phase clearance of virus but was required for efficient clearance of virus at later stages of infection. Finally, transcriptional analyses indicated that induction and duration of key innate immune gene programs may explain differences in age-dependent disease severity. Importantly, these data demonstrate that SARS-CoV-2-mediated disease in C57BL/6 mice accurately phenocopies human disease across ages and establishes a platform for future therapeutic and genetic screens for not just SARS-CoV-2 but also novel coronaviruses that have yet to emerge.

Identifiers

PMID36415465
PMCPMC9681052
OpenAlexW4308952004

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.